Publishing intelligence

Lately there has been a lot of buzz around the term Web 2.0. The term is often used to define the next generation of the internet. For those not so familiar with the term, Web 2.0 simply describes the next evolution of the internet, and how people are using it. Web 1.0 (circa 2003 and earlier) was ‘static’; the user was at the mercy of how a website organized its content on static pages. Even more cumbersome during the Web 1.0 days was the need to access multiple websites to pull relevant information together. With the emergence of Web 2.0, the utility value of the internet has dramatically improved – driven now by user-specified informational needs. Successful businesses in the ‘dynamic’ Web 2.0 online space will be those which effectively aggregate disparate content to provide one-click access to relevant information from one web portal.

One web portal – one global view

In this next generation of web-based solutions, high value is placed on smart aggregation. One of the unique developments enabled by Web 2.0 is a web-based communications network portal (COMM-NET) that dynamically links the major elements of publications, i.e. authors, journals, types of publication (e.g. editorials, review articles, articles relating to clinical trials, articles about specified drugs), and centers of publication. This analysis results in a dataset within a specified disease area and time period, based on the evaluation of all worldwide medical publications relating to the specified disease, over a specified time period.

This dataset can be viewed from the angle of any one of the above mentioned publication elements, and relationships can be explored between any of the specified elements

Major benefits to the pharmaceutical industry

A great advantage is that this integrated dynamic network linking all the specified elements can be tracked over time, both historically and prospectively, in a highly economic manner. In addition, the web-based deliverable, ensures instant, universal (pass-worded) access.

In conclusion

The objective of such a web-based “communications network” is to bring together all the related information originating from the top authors, journals, centers of publication and drug-mentioned publishing into a single point of access. In turn, the end user can access information from the point of view of the disease, a specific journal, top authors, centers of publications, or the published mention of specific drugs. These different gateways to related information also allows various departments within a pharmaceutical company access to publishing intelligence from their point of view and context – whether that end user represents the mindset of clinical affairs, marketing research, product marketing, or publication strategy. In this model, one size that fits all, is truly achievable.

Web-based solutions that aggregate all topic-related publishing intelligence and bring it all together for immediate, single source access, offer a compelling value proposition to the pharmaceutical industry.